​

Funding Round

Series A - PanOptica

Series A - PanOptica

Investment Firm

Overview

PanOptica is a biopharma company developing ophthalmic therapeutics for the treatment of eye diseases.

Announced Date

Jan 04, 2011

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Third Rock Ventures

Third Rock Ventures

Third Rock Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed firm.

SV Health Investors

SV Health Investors

SV Health Investors is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorAstellas Venture Management
Participant InvestorSV Health Investors
Participant InvestorThird Rock Ventures

Round Details and Background

PanOptica raised $30000000 on 2011-01-04 in Series A

PanOptica is a biopharma company developing ophthalmic therapeutics for the treatment of eye diseases.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 06, 2017
Series B - PanOptica
2-11.0M
Jan 07, 2016
Series B - PanOptica
1-undefined
May 27, 2016
Series B - PanOptica
3-23.9M
Jan 04, 2011
Series A - PanOptica
3-30.0M

Recent Activity

There is no recent news or activity for this profile.